As one of the first National Cancer Institute–designated comprehensive cancer centers in the country, USC Norris is among only a few university-based institutions in which research, patient care and education are inextricably intertwined and upon which the nation depends for a steady stream of new knowledge. Our scientists seek to pinpoint the causes of cancer, identify better methods of diagnosis and treatment, develop strategies to prevent cancer and promote health, and understand how environmental factors influence our health. New developments in molecular biology, genomics, and related technologies allow researchers and physicians to tailor each patient’s medical care to his or her needs during diagnosis, treatment and follow-up. USC Norris offers access to more than 170 innovative clinical trials, testing new therapies for cancer, optimizing existing treatments, discovering prevention methods, and developing ways to improve patients’ quality of life.

USC Norris is led by Director Stephen B. Gruber, MD, PhD, MPH, a distinguished medical oncologist, cancer geneticist and epidemiologist whose research focuses on genetic and environmental contributions to cancer. Our nationally and internationally renowned physician scientists represent extensive areas of expertise including the following: blood diseases, bone marrow transplantation, breast cancer, colorectal cancer, genetic counseling, gynecological cancers, head and neck cancers, lung cancer, melanoma, neurological cancer, prostate cancer, radiation oncology, sarcoma and urologic oncology.

Learn more about our clinical research
Learn more about our translational research

Clinical Trials

Did you know?…

At any time, there may be more than 300 clinical trials taking place at the USC Norris Comprehensive Cancer Center in Los Angeles. As a leader in cancer research, we are home to more than 250 members who investigate the complex origins and progression of cancer, develop prevention strategies and search for cures.
Learn More